Title | Type | SJR | H index | Total Docs. (2019) | Total Docs. (3years) | Total Refs. (2019) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2019) | %Female (2019) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Oncology Reports | journal | 0.968 Q3 | 115 | 585 | 2335 | 26020 | 7896 | 2335 | 3.36 | 44.48 | 39.95 | |
52 | Infectious Agents and Cancer | journal | 0.955 Q3 | 47 | 47 | 157 | 1631 | 509 | 157 | 2.98 | 34.70 | 41.42 | |
53 | Experimental Hematology and Oncology | journal | 0.941 Q3 | 42 | 31 | 94 | 1280 | 305 | 92 | 3.66 | 41.29 | 39.77 | |
54 | Oncology | journal | 0.932 Q3 | 107 | 80 | 340 | 2333 | 895 | 331 | 2.64 | 29.16 | 28.91 | |
55 | Cancer Gene Therapy | journal | 0.930 Q3 | 99 | 42 | 152 | 1296 | 670 | 147 | 3.98 | 30.86 | 34.94 | |
56 | Familial Cancer | journal | 0.919 Q3 | 67 | 64 | 246 | 1866 | 500 | 233 | 1.70 | 29.16 | 56.36 | |
57 | Leukemia and Lymphoma | journal | 0.886 Q3 | 102 | 545 | 1369 | 14619 | 2242 | 797 | 1.69 | 26.82 | 44.11 | |
58 | Cancer Microenvironment | journal | 0.877 Q3 | 51 | 16 | 40 | 1472 | 117 | 39 | 2.52 | 92.00 | 50.60 | |
59 | Cancer Biomarkers | journal | 0.874 Q3 | 54 | 157 | 542 | 5048 | 1720 | 542 | 3.10 | 32.15 | 41.50 | |
60 | Angiogenesis | journal | 0.839 Q3 | 101 | 47 | 141 | 2254 | 1012 | 139 | 8.33 | 47.96 | 44.95 | |
61 | Future Oncology | journal | 0.837 Q3 | 90 | 414 | 932 | 16241 | 1952 | 828 | 2.22 | 39.23 | 38.65 | |
62 | Clinical and Translational Oncology | journal | 0.833 Q3 | 61 | 202 | 526 | 7868 | 1330 | 514 | 2.56 | 38.95 | 41.04 | |
63 | Journal of Oral Pathology and Medicine | journal | 0.809 Q3 | 95 | 131 | 424 | 3843 | 1132 | 399 | 2.69 | 29.34 | 39.20 | |
64 | Leukemia Research | journal | 0.780 Q3 | 96 | 147 | 568 | 4021 | 1189 | 507 | 2.07 | 27.35 | 43.10 | |
65 | Human Cell | journal | 0.758 Q3 | 44 | 56 | 94 | 1954 | 260 | 91 | 3.16 | 34.89 | 43.06 | |
66 | Japanese Journal of Clinical Oncology | journal | 0.758 Q3 | 95 | 210 | 566 | 5497 | 1185 | 526 | 1.81 | 26.18 | 20.06 | |
67 | Hematological Oncology | journal | 0.728 Q3 | 54 | 119 | 307 | 3095 | 618 | 263 | 2.07 | 26.01 | 47.52 | |
68 | Anticancer Research | journal | 0.716 Q3 | 136 | 843 | 2719 | 26585 | 5498 | 2716 | 2.12 | 31.54 | 30.59 | |
69 | International Journal of Hyperthermia | journal | 0.704 Q3 | 98 | 181 | 473 | 7119 | 1363 | 443 | 2.73 | 39.33 | 33.47 | |
70 | Pathology and Oncology Research | journal | 0.692 Q3 | 61 | 199 | 357 | 6562 | 750 | 329 | 2.21 | 32.97 | 41.70 | |
71 | Oncology Letters | journal | 0.673 Q3 | 81 | 1473 | 5605 | 56631 | 12901 | 5605 | 2.35 | 38.45 | 38.55 | |
72 | Molecular Medicine Reports | journal | 0.630 Q3 | 86 | 1149 | 4978 | 46424 | 11151 | 4977 | 2.12 | 40.40 | 42.64 | |
73 | Molecular and Cellular Oncology | journal | 0.580 Q3 | 37 | 85 | 440 | 859 | 514 | 375 | 1.03 | 10.11 | 46.02 | |
74 | ecancermedicalscience | journal | 0.572 Q3 | 47 | 115 | 297 | 4257 | 543 | 297 | 1.82 | 37.02 | 44.92 | |
75 | Oncology Research and Treatment | journal | 0.558 Q4 | 55 | 113 | 432 | 2585 | 511 | 377 | 1.16 | 22.88 | 37.07 | |
76 | International Journal of Biological Markers | journal | 0.557 Q4 | 47 | 57 | 193 | 1776 | 330 | 185 | 1.75 | 31.16 | 41.53 | |
77 | Experimental and Therapeutic Medicine (discontinued) | journal | 0.508 Q4 | 63 | 0 | 3990 | 0 | 7225 | 3983 | 1.80 | 0.00 | 0.00 | |
78 | Pathogenesis | journal | 0.502 Q4 | 8 | 0 | 3 | 0 | 6 | 3 | 0.00 | 0.00 | 0.00 | |
79 | In Vivo | journal | 0.458 | 72 | 308 | 546 | 9733 | 896 | 546 | 1.67 | 31.60 | 30.80 | |
80 | Tumori | journal | 0.412 Q4 | 59 | 101 | 367 | 2527 | 426 | 346 | 1.29 | 25.02 | 46.29 | |
81 | Journal of Biological Regulators and Homeostatic Agents | journal | 0.395 Q4 | 56 | 411 | 886 | 7705 | 1272 | 846 | 1.47 | 18.75 | 38.61 | |
82 | Journal of B.U.ON. | journal | 0.392 Q4 | 37 | 409 | 846 | 9704 | 1111 | 756 | 1.39 | 23.73 | 39.45 | |
83 | European Journal of Cancer, Supplement | journal | 0.383 Q4 | 29 | 0 | 1 | 0 | 3 | 1 | 0.00 | 0.00 | 0.00 | |
84 | Breast Disease | journal | 0.302 Q4 | 36 | 17 | 58 | 425 | 52 | 58 | 0.97 | 25.00 | 51.16 | |
85 | Bulletin du Cancer | journal | 0.298 Q4 | 44 | 168 | 544 | 5191 | 378 | 438 | 0.76 | 30.90 | 54.32 | |
86 | International Journal of Cancer Management | journal | 0.277 Q4 | 26 | 72 | 343 | 2274 | 263 | 328 | 0.56 | 31.58 | 43.44 | |
87 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.272 Q4 | 50 | 3 | 47 | 120 | 37 | 41 | 0.19 | 40.00 | 0.00 | |
88 | Cancer Treatment and Research Communications | journal | 0.256 Q4 | 23 | 32 | 117 | 961 | 77 | 116 | 0.55 | 30.03 | 40.09 | |
89 | Progress in Tumor Research | book series | 0.254 Q4 | 12 | 0 | 22 | 0 | 22 | 22 | 0.10 | 0.00 | 0.00 | |
90 | Molecular and Clinical Oncology | journal | 0.213 Q4 | 19 | 114 | 2 | 3370 | 0 | 2 | 0.00 | 29.56 | 24.43 | |
91 | Cancer Treatment and Research | journal | 0.191 Q4 | 65 | 58 | 117 | 5358 | 192 | 20 | 0.98 | 92.38 | 0.00 | |
92 | Atlas of Genetics and Cytogenetics in Oncology and Haematology | journal | 0.105 Q4 | 4 | 91 | 108 | 1685 | 3 | 108 | 0.03 | 18.52 | 54.62 | |
93 | Gaceta Mexicana de Oncologia | journal | 0.105 Q4 | 7 | 39 | 159 | 1822 | 14 | 141 | 0.09 | 46.72 | 37.14 | |
94 | Cancer Reports | journal | 18 | 62 | 20 | 3690 | 7 | 19 | 0.35 | 59.52 | 43.62 | ||
95 | Cell Stress | journal | 27 | 38 | 64 | 3331 | 58 | 61 | 0.91 | 87.66 | 46.31 | ||
96 | Discover Oncology | journal | 44 | 21 | 110 | 932 | 267 | 108 | 2.44 | 44.38 | 39.07 | ||
97 | FASEB BioAdvances | journal | 18 | 58 | 0 | 2798 | 0 | 0 | 0.00 | 48.24 | 37.60 | ||
98 | npj Precision Oncology | journal | 36 | 33 | 28 | 1965 | 151 | 27 | 5.39 | 59.55 | 41.26 | ||
99 | South Asian Journal of Cancer | journal | 25 | 79 | 221 | 1468 | 210 | 150 | 0.74 | 18.58 | 35.25 | ||
100 | Tumour Virus Research | journal | 34 | 56 | 118 | 2012 | 372 | 112 | 3.01 | 35.93 | 55.22 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®